From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor TherapyCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52024-04-240OAAI
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA TrialJOURNAL OF CLINICAL MEDICINEIF2.92022-10-283OAAI
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA TrialJOURNAL OF CLINICAL MEDICINEIF2.92022-08-046OAAI
Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA StudyCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52021-07-1815OAAI
New Oral Anti-Cancer Drugs and Medication Safety新型口服抗癌药物与用药安全DEUTSCHES ARZTEBLATT INTERNATIONALIF7.12019-11-1539OA